Phenolic Acids / AntiAg Cancer Research Results

Phen, Phenolic Acids: Click to Expand ⟱
Features: 
Phenolic / Polyphenol Comparison Matrix including:
-Gallic acid (GA)
-Caffeic acid (CA)
-Ferulic acid (FA)
-Ellagic acid (EA)
-DHCA (3,4-dihydroxycinnamic acid variant class)
-HCAs (general hydroxycinnamic acids class)
-Rosmarinic acid
-Propolis (CAPE-rich context)
-Perilla (rosmarinic-rich context)
-Moringa
-Date fruit extract

True Phenolic Acids (GA, CA, FA, EA, DHCA, HCAs)
-Core identity: redox modulators
-Anti-inflammatory signature: NF-κB ↓
-Nrf2 activation common in normal tissue
-Tumor cytotoxicity usually requires ≥10–50 µM
-Bioavailability often limiting

Polyphenol-Rich Extracts (Propolis, Perilla, Moringa, Date)
-Effects depend on composition
-Strongest NF-κB inhibition: Propolis (CAPE)
-Strongest biphasic redox: Gallic, Caffeic
-Weakest direct tumor evidence: Date fruit extract
Phenolic / Polyphenol Comparison Matrix
(Cancer-Focused Mechanistic Orientation)
Tier Compound / Extract Class Redox Behavior Nrf2 (Normal) Nrf2 (Cancer) NF-κB PI3K/AKT Apoptosis Angiogenesis Pro-Ox Threshold Primary Limitation
Tier 1
Strong Redox Cytotoxic		 Gallic Acid Hydroxybenzoic acid Biphasic ↑ Context ↓ ↓ (reported) ↑ (ROS-mediated) ↓ (reported) ~50–100 µM Rapid conjugation
Tier 1 Caffeic Acid Hydroxycinnamic acid Biphasic (Cu-sensitive) ↑ Context ↓ ↓ (reported) ↑ (context) ↓ (reported) Metal-dependent Low systemic free levels
Tier 1 Propolis (CAPE-rich) Polyphenol mixture Biphasic ↑ ↓ (reported in some) ↓↓ (strong) ↓ ↑ (robust preclinical) ↓ Moderate Composition variability
Tier 1 DHCA Hydroxycinnamic acid variant Biphasic ↑ Context ↓ ↓ (reported) ↑ (reported) Limited data Model-dependent Sparse data
Tier 2
Moderate Redox Modulators		 Ellagic Acid Ellagitannin-derived Mainly antioxidant ↑ Context ↓ ↓ ↑ (reported) ↓ Weak Very poor bioavailability
Tier 2 Rosmarinic Acid Caffeic ester (polyphenol) Mainly antioxidant ↑ Context ↓ ↓ (reported) ↑ (modest) ↓ Low pro-ox Low bioavailability
Tier 2 Moringa Polyphenol + isothiocyanate mix Mixed (antioxidant + pro-ox possible) ↑ Context ↓ ↓ ↑ (reported) ↓ Model-dependent Complex phytochemistry
Tier 2 Perilla Rosmarinic-rich extract Mainly antioxidant ↑ Context ↓ ↓ (reported) ↑ (mild) Limited Weak Extract variability
Tier 3
Primarily Antioxidant / Supportive		 Ferulic Acid Hydroxycinnamic acid Mainly antioxidant ↑ Context ↓ ↓ (mild) ↑ (modest) ↓ (reported) Weak pro-ox Phase II metabolism
Tier 3 HCAs (general class) Phenolic acid class Mainly antioxidant ↑ Context ↓ ↓ (variable) ↑ (modest) ↓ (reported) Weak Rapid metabolism
Tier 3 Date Fruit Extract Polyphenol mixture Mainly antioxidant ↑ Likely supportive ↓ Limited data Weak cytotoxic data Limited Minimal Low tumor-specific evidence


AntiAg, Antiplatelet aggregation: Click to Expand ⟱
Source:
Type:
Antiplatelet aggregation refers to the process by which platelets clump together to form a blood clot.
The plethora of evidence indicates that among multiple hemostasis components, platelets play major roles in cancer progression by providing surface and granular contents for several interactions as well as behaving like immune cells.On the other hand, there are suggestions that antiplatelet treatment may promote solid tumor development in a phenomenon described as “cancers follow bleeding.” The controversies around antiplatelet agents justify insight into the subject to establish what, if any, role platelet-directed therapy has in the continuum of anticancer management.
The interplay between antiplatelet aggregation and cancer is an area of active research, with potential implications for therapeutic strategies. Antiplatelet agents, such as aspirin, are being investigated for their role in cancer prevention and treatment, particularly in reducing metastasis and improving patient outcomes.
Scientific Papers found: Click to Expand⟱
7519- Phen,  HCAs,    Neuroprotective role of phenolic acids: mechanistic insights into cognitive decline and neurodegenerative disorder
- Review, AD, NA
*antiOx↑, *Inflam↓, *Apoptosis↓, *AntiAg↑, *NRF2↑, *HO-1↑, *NF-kB↓, *PI3K↑, *Akt↑, *cognitive↑, *neuroP↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,   HO-1↑, 1,   NRF2↑, 1,  

Cell Death(tgid=5) ⓘ

Akt↑, 1,   Apoptosis↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

PI3K↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

Inflam↓, 1,   NF-kB↓, 1,  

Functional Outcomes(tgid=23) ⓘ

cognitive↑, 1,   neuroP↑, 1,  
Total Targets: 11

Scientific Paper Hit Count for: AntiAg, Antiplatelet aggregation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:393  Target#:10  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page